Differences of Sex Development (DSD) Panel
Use
This panel is intended for individuals with relevant features who have a clinical or suspected diagnosis of Disorders/Differences of Sex Development (DSD). It is also useful for individuals presenting with syndromic or non-syndromic conditions requiring genetic diagnosis, including those needing evaluation for sex chromosome abnormalities or copy number variants.
Special Instructions
This test is performed using either the Exome or Genome Platform, with the option for STAT testing to expedite results. Additional options include Exome-Wide CNV Analysis and prenatal testing.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. Performance characteristics were validated by PreventionGenetics LLC under CAP and CLIA regulations. Possible limitations may include difficulty detecting all types of variants, such as large insertions/deletions or repeats.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided